Table 4 Main model analysis by sex, age, ethnicity, and deprivation: incremental costs, QALYsDW gained and ICERs for the CCC intervention compared to business-as-usual
From: Cancer care coordinators in stage III colon cancer: a cost-utility analysis
Population | Incremental costs per patient (NZ$) | QALYsDW gained per patient | ICER (NZ$ per QALYDW) |
|---|---|---|---|
Total (expected value analysis)a | $2250 | 0.111 | $20,200 |
By sex | |||
Males | $2050 | 0.118 | $17,400 |
Females | $2520 | 0.121 | $20,800 |
By age | |||
< 65 years | $1620 | 0.172 | $9,400 |
≥ 65 years | $2490 | 0.106 | $23,600 |
By ethnicity by age | |||
Māori | $3420 | 0.171 | $20,000 |
< 65 years | $2810 | 0.223 | $12,600 |
≥ 65 years | $3730 | 0.147 | $25,300 |
Non-Māori | $2220 | 0.118 | $18,800 |
< 65 years | $1510 | 0.167 | $9,000 |
≥ 65 years | $2420 | 0.104 | $23,300 |
By deprivation | |||
Least deprived tertile | $1880 | 0.125 | $15,000 |
Most deprived tertile | $2620 | 0.115 | $22,800 |
Equity analysis: using non-Māori least deprived mortality and non-Māori average background morbidity | |||
By ethnicity by age (percentage variation from equivalent above standard analysis) | |||
Māori | $3,780 (11 %) | 0.251 (47 %) | $15,100 (−25 %) |
< 65 years | $3,250 (16 %) | 0.317 (42 %) | $10,300 (−18 %) |
≥ 65 years | $4,070 (9 %) | 0.222 (51 %) | $18,400 (−27 %) |
Non-Māori | $2,240 (1 %) | 0.121 (3 %) | $18,500 (−2 %) |
< 65 years | $1,540 (2 %) | 0.171 (2 %) | $9,000 (0 %) |
≥ 65 years | $2,430 (0 %) | 0.107 (3 %) | $22,800 (−2 %) |